Related Experiment Video
Updated: Aug 14, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
SmokeChange for changing smoking in pregnancy
R P Ford1, S F Cowan, P J Schluter
1Community Paediatric Unit, Christchurch. rodneyf@chhlth.govt.nz
Aim:
To measure the extent to which SmokeChange, a personalised intervene, enabled pregnant women to rede their exposure to tobacco smoke.
Methods:
A cross-section of general medical practices was randomly selected. General Practitioners (GPs) were to register all pregnant women with the SmokeChange programme. Smoking women were contacted by a SmokeChange Educator, who visited them at home. The Educator worked with women and their families for up to twelve months in order to support cognitive, environmental and behavioural changes to smoking.
Results:
GPs registered 1,390 pregnant women. Current smoking, was reported by 437 (31.4%) and 209 (47.8% of smokers) chose to enrol with the SmokeChange intervention programme. of these, 149 women (34.1% of smokers) continued with the programme for at least four visits. From this 'long' participation group, 28 (18.8%) had stopped smoking entirely by their last visit in pregnancy. Another 26 (17.4%) reported at least one cessation attempt, together with a reduction of smoking consumption by 63% at the end of pregnancy. The 95 (63.8%) continued smokers had reduced their smoking consumption by 40%. Substantial smokefree environment (homes and cars) changes were also made.
Conclusions:
The SmokeChange approach of personalised intervention, matched to individual readiness for change, was both acceptable to pregnant women and enabled participants to substantially reduce tobacco toxin exposure to themselves and their developing infants.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress Prevention and Stress Management Techniques IV
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features